Monday brought a fresh batch of analyst initiations, with Wall Street firms launching coverage on five companies spanning healthcare, streaming entertainment, and professional services.
Leading the bullish calls, HSBC analyst Mohammed Khallouf initiated coverage on Netflix Inc (NFLX) with a Buy rating and a $107 price target. That represents nearly 20% upside from the stock's Friday closing price of $89.44, signaling strong conviction in the streaming giant's prospects.
On the healthcare front, BMO Capital analyst Sean Dodge started coverage of Medline Inc (MDLN) with an Outperform rating and $45 price target. The medical supply company closed at $40.52 on Friday, giving the target roughly 11% upside potential.
Evercore ISI Group analyst Mark Mahaney took a more neutral stance on Hims & Hers Health Inc (HIMS), initiating coverage with an In-Line rating and $33 price target. The telehealth platform's shares ended Friday's session at $31.69, putting the target just above current trading levels.
UBS analyst Kevin Mcveigh launched coverage on Andersen Group Inc (ANDG) with a Buy rating and $28 price target. The professional services firm closed at $24.29 on Friday, suggesting potential upside of about 15% if the target is reached.
Rounding out Monday's initiations, JP Morgan began covering Fulcrum Therapeutics Inc (FULC) with an Overweight rating and $20 price target. That's particularly noteworthy given the biotech company's Friday close of $9.85, implying the analysts see potential for the stock to more than double.
These coverage initiations give investors fresh perspectives on companies that may have previously flown under the radar at these particular firms. Analyst ratings can move stocks, especially when a major Wall Street bank takes an initial public stance on a company's prospects.
